 Mitchell Freeman from Accutrax is about to tell us about a pair of AR glasses that are supposed to be able to start helping people with macular degeneration. That's a topic very interesting to me. It's a loss of sight due to damage in the retina from a very specific cause. But let's talk about what you're working on here. Yeah, so this is central vision loss. It runs in my family like in yours. My father had this. So these AR glasses, you put them on, it does a visual field test on the headset. Then it defines what the defect is in each eye. The defect is called a scatoma. And then we create what we call a scatoma marker on the live video feed. So whatever they're looking at, it moves the visual information out to the edges where they still have good retina. And it's really exciting because people haven't been able to read in years after just a few moments of wearing this headset, they start reading at a regular rate. We have several different modes. Because this is what we built this headset for, we have to be able to correct over a wide field of view. We have the widest field of view of any AR glasses out there, 60 degree field of view, 5K resolution. We think it will have a lot of other uses, but where our heart is is helping people with macular degeneration. So is your brain adapting to this information now moving from the dead spot out to the outer periphery of your vision? It really is. The brain does an amazing job of interpreting for the eyes. So when you have that blind spot, it's a very frustrating thing. My father told me that. But this basically helps their brain perceive words again. They can often see one or two letters at a time. I remember my dad trying to collect the letters in his brain and then read it in his head. That's very laborious. But with this technology, people can sight read it. You know, you read by grabbing the whole word at a time. So now they can see the whole word. They take off reading at a regular rate. It is so exciting. Hopefully the other interview will play right before this one, maybe. But we were with the people who had created a headset that simulates macular degeneration. And it was a really, really frustrating thing. I liken it to when you try to look at a star and you can't see it. But if you look away, you can see it. It's like that. It's like you've got this dead spot in the middle of your vision. If you look away, you can see it in the periphery. But you're saying they could look right at something and now it's going to collect that information and put it to the sides of their vision? So what some of the optical therapists do is they try to teach them to look off to the side and focus on that. What this kind of allows them to do is use both sides of the good retina because we're stretching all the visual effort. Like the word is now stretched out and so they don't have to kind of have that training. They can just start reading as they seem to be able to just read and pick it up. I've got to tell you, this sounds too good to be true. My dad said, this is very frustrating. We need to do something to help people. So when he was still alive, we filed some patents, had some ideas on how to do this. Actually one of the first things that kind of pointed this out to us, remember back in the day when there was a lot of curved TVs? We were testing different things out and we had him look at a curved TV and he said, you know I can't see the 50 yard line but I can see more than I could back here. So that's kind of what headed us down this path to kind of get the visual information where they still have good part of the retina. All right, well so Oculense is what it's called. It's ARMRXR. It's got all the Rs. It's got AI. It's not VR because we still want the patient to be able to see through there if they need to so it overlays. But if they lose power they can still see through them and see the world. It's a good idea. So when would you expect a product like this to be on the market? You know these are our final prototypes that we're doing trials with patients and we think we'll be able to start shipping second quarter. Really? Really? Do you have to go through any FDA approval or anything? This is 510K exempt but we're still doing some of the FDA trials because the next people that want to use this are surgeons. They saw this for the patient. They go, we need this for surgery so we can comfortably, you know, it's very uncomfortable looking in the oculars for hours. So yeah, it's very lightweight, very comfortable. We've had a lot of comments today that this is so lightweight. The battery, we were running this yesterday for six hours. It's got a battery that'll come off. We're very excited about this. These are all 3D printed parts. We're in production on most of this right now with the injection molding. So we'll put all this together really quickly. It has the XR2 chipset in here. It's running multiple cameras. It's doing everything your phone can do, plus a little bit more. We think this will really become the phone for low vision people. We had a young lady that had Stargard's, a juvenile version of Mackler degeneration. She had her PhD. She was teaching but she'd done everything by just listening to it. She put this on. She had a very large defect in her eye in both eyes. She put this on, started reading and then we turned on the video and she was like, oh, this is so clear. She was, you know, she tries to watch a video but she was so excited to be able to watch a video. That must have been so transformative. How fantastic. All right. So if people want to learn more, where would they go? Just look for the OcuTrex. OcuTrex is spelled O-C-U-T-R-X.com. Very good. All right. Thank you very much, Mitchell. Thank you guys for coming by. Thanks.